Investment Strategy
1 minute read
The Agony & The Ecstasy
Trending Insights
-
01
-
02
-
03
If you’re like many senior executives, the turn of a new year marks the end of one compensation period and the beginning of another. As you receive your annual incentive payment—typically in cash and deferred stock grants—you’ll want to think about how to enhance your future proceeds and minimize your taxes. The decisions you make now could impact your financial objectives.
Determining the best course of action can be challenging. In the first quarter, many executives will see their company stock concentrations rise as their restricted stock units (RSUs) or performance-based stock units (PSUs) vest into their accounts. This shift necessitates careful and strategic decision making. Should you sell your vested stock immediately and use the proceeds to diversify your portfolio? Or, if you’re optimistic about the company’s earnings potential, should you hold on to vested stock in case it appreciates? And what are your options if you don’t want to sell it all at once—would a staggered sale, stock transfer or combined approach work best?
To help guide you through the planning process, we’ve laid out five key questions to consider. While these choices are focused primarily on newly vested stock grants, you may want to think about reviewing all of your savings and investment elections—including deferred compensation plans and 401(k) contributions—to ensure you’re on track to meet your future wealth goals.
Before selling your newly vested RSUs and PSUs, it’s important to be aware of various restrictions designed to ensure compliance with legal, ethical and strategic considerations. These constraints may include:
Once those conditions have been met, selling your newly vested RSUs and PSUs should be fairly straightforward. However, more questions may soon arise, particularly around timing and execution.
If you’re satisfied that the stock is fairly valued, your best choice may be to accept your fresh round of new RSUs or PSUs, which will be taxed as they vest, and then sell them to maintain your desired portfolio allocation. Unless the stock experiences significant price movement, the tax implications of the sale are likely to be minimal. (As a reminder, however, public company executives, especially named executive officers, should always consult with their companies’ general counsels prior to initiating sales.)
Why might this be the most practical approach? Because your compensation package will reload annually with fresh RSUs and PSUs that won’t fully vest for some time, your total future compensation—and exposure to company stock—may continue to rise. Although collecting an abundance of unvested stock can be a welcome planning challenge, the added equity can easily start to tilt your portfolio allocation if it vests and remains unsold.
Selling your newly vested RSUs and PSUs may be the best way to diversify your investment portfolio and reduce risk. If you’re a senior executive, remember that your employment and compensation are also inexorably tied to your company, so it’s a good idea to use the vesting season to dial down your own personal financial exposure.
If you’re hesitant to sell all of your newly vested RSUs and PSUs straightaway, or if you don’t want to sell at the current share price, you have several planning options.
For executives of public companies, the most powerful financial tool at your disposal may be a 10b5-1 plan, a trading contract that allows corporate leaders to buy and sell company stock on a predetermined schedule. If, for example, the stock drops from $70 per share to $50 per share shortly prior to the payment of your annual bonus—and you believe the stock is temporarily undervalued—you could set up a 10b5-1 plan to sell your vesting shares gradually, at different price points, as long as those dates and prices are set in advance.
If you’re not inclined to set up a 10b5-1 plan, you can always revisit the possibility of a sale at the next quarterly trading window. The window for senior executives typically begins two to three trading days after the previous quarter’s earnings release, and ends approximately two to three weeks prior to the end of the next fiscal quarter, resulting in a permitted trading period of about six weeks.
Individuals who are not considered insiders or subject to hedging and pledging restrictions at public companies may have access to various different hedging and monetization strategies.
This year, we would encourage you to take advantage of the generous gift and estate tax exemptions currently available under the Tax Cuts and Jobs Act (TCJA) of 2017, which sunsets on December 31, 2025. Under the TCJA, federal estate, gift and generation-skipping transfer (GST) tax exemptions are nearly double their historical levels. Individual donors may make lifetime transfers of up to $13.99 million (adjusted for inflation); couples may make lifetime transfers up to $27.98 million without incurring federal estate or gift taxes.
The U.S. Congress may decide to extend some or all of the provisions of the TCJA that are scheduled to sunset at the end of 2025. No one yet knows the outcome of that debate. For now, you can still make significant transfers of newly vested stock to your spouse (and potentially your children, too), through different types of tailored, tax-efficient trusts. The most popular are:
For some executives, combining these approaches may yield the most tax-efficient outcome. You could choose, for example, to retain your newly vested shares and gift your shares with a lower cost basis as a way to contain—and limit—equity concentration in your portfolio (and minimize any potential capital gains tax). It’s also possible to gift shares with a low- or no-cost basis to charity via your DAF, and thus realize a charitable gift income tax exclusion.
For executives who want to transfer wealth to their beneficiaries in 2025, consider gifting your shares with a lower cost basis to children or grandchildren. Young beneficiaries may be able to sell some of the shares at a lower capital gains rate, or retain their new shares and accumulate dividends at a lower tax rate.
Conclusion: Make strategic decisions now to optimize your future wealth
As the new year unfolds, it’s crucial to take a proactive approach to managing your annual compensation package and benefit plan. Now is the time to review your current investment elections because the decisions you make can have a lasting impact on your financial future, influencing everything from portfolio diversification to tax efficiency.
By carefully evaluating your options as your RSUs and PSUs vest this year—whether to sell, hold or use a combination of planning strategies—you can align your actions with your financial objectives. Remember, the key is to stay flexible and informed as market conditions evolve, ensuring that your financial strategies remain aligned with your long-term wealth goals.
At J.P. Morgan, our team of specialists is here to provide personalized guidance tailored to your specific needs and circumstances. Whether you’re considering selling your newly vested shares, exploring tax-efficient gifting strategies or seeking to optimize your overall wealth plan, we have the tools and expertise to support you.
Speak with your J.P. Morgan advisor today to explore how we can help you make the most of your equity compensation and achieve your long-term financial goals.
1The “applicable federal rate” (AFR) is the minimum interest rate set by the Internal Revenue Service for private loans and certain financial transactions. In the context of a grantor retained annuity trust (GRAT), the AFR is normally used to calculate the annuity payments and the expected return on the trust’s assets. The appreciation beyond this rate can pass to beneficiaries free of gift tax.
We can help you navigate a complex financial landscape. Reach out today to learn how.
Contact usLEARN MORE About Our Firm and Investment Professionals Through FINRA BrokerCheck
To learn more about J.P. Morgan’s investment business, including our accounts, products and services, as well as our relationship with you, please review our J.P. Morgan Securities LLC Form CRS and Guide to Investment Services and Brokerage Products.
JPMorgan Chase Bank, N.A. and its affiliates (collectively "JPMCB") offer investment products, which may include bank-managed accounts and custody, as part of its trust and fiduciary services. Other investment products and services, such as brokerage and advisory accounts, are offered through J.P. Morgan Securities LLC ("JPMS"), a member of FINRA and SIPC. Insurance products are made available through Chase Insurance Agency, Inc. (CIA), a licensed insurance agency, doing business as Chase Insurance Agency Services, Inc. in Florida. JPMCB, JPMS and CIA are affiliated companies under the common control of JPMorgan Chase & Co. Products not available in all states.
Please read the Legal Disclaimer for key important J.P. Morgan Private Bank information in conjunction with these pages.
Bank deposit products, such as checking, savings and bank lending and related services are offered by JPMorgan Chase Bank, N.A. Member FDIC.
Not a commitment to lend. All extensions of credit are subject to credit approval.